. Author manuscript; available in PMC: 2014 Jun 1.

Published in final edited form as: Glob Heart. 2013 May 7;8(2):10.1016/j.gheart.2012.12.002. doi: 10.1016/j.gheart.2012.12.002

Table 1. GHb is a Better Predictor of 8-year Fatal CVD & CHD in Women but not Men w/o Diabetes.

	Men	Women
	HR (95% Cl)	HR (95% Cl)
CVD mortality
GHb	1.10 (0.61-1.97)	2.61 (1.40-4.88)
FPG	0.75 (0.39-1.46)	1.30 (0.61-2.81)
PCG	0.83 (0.47-1.45)	1.01 (0.51-2.00)
CHD mortality
GHb	1.25 (0.56-2.78)	2.59 (1.14-5.85)
FPG	0.98 (0.42-2.30)	0.98 (0.34-2.80)
PCG	0.90 (0.41-1.96)	0.87 (0.34-2.21)

Adjusted for age, systolic blood pressure, body mass index, LDL, HDL, triglycerides, smoking, anti-hypertension medications, and estrogen therapy use in women GHb (glycosylated hemoglobin); FPG (fasting plasma glucose) PCG (post-challenge glucose); CVD (cardiovascular disease); CHD (coronary heart disease); HR (hazard ratio); CI (confidence interval)

Adapted from S Park et al., Diabetes Care, 1996;19:450-456.